Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma to the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03323463
What this trial is testing

Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma

Who this might be right for
HPV-Associated Oropharyngeal Squamous Cell CarcinomaSquamous Cell Carcinoma of the Neck
Memorial Sloan Kettering Cancer Center 316
Testing effectiveness (Phase 2)Study completedNCT04282109
What this trial is testing

Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 141
Testing effectiveness (Phase 2)Study completedNCT00824343
What this trial is testing

A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Piramal Enterprises Limited 86
Testing effectiveness (Phase 2)Looking for participantsNCT06208826
What this trial is testing

A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy

Who this might be right for
Head and Neck Cancer
Tianjin Medical University Cancer Institute and Hospital 268
Not applicableStudy completedNCT00415025
What this trial is testing

Side Effects of High-Dose Intensity-Modulated Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerLong-term Effects Secondary to Cancer Therapy in AdultsOral Complications of Radiation Therapy+1 more
University of Wisconsin, Madison 20
Early research (Phase 1)Ended earlyNCT03780725
What this trial is testing

This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091

Who this might be right for
Carcinoma, Non-Small-Cell LungHead and Neck Neoplasms
Boehringer Ingelheim 8
Testing effectiveness (Phase 2)Ended earlyNCT00566540
What this trial is testing

Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Cancer

Who this might be right for
Head and Neck Cancer
Ohio State University Comprehensive Cancer Center 11
Post-approval studies (Phase 4)Study completedNCT04489888
What this trial is testing

Pembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10)

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Merck Sharp & Dohme LLC 101
Testing effectiveness (Phase 2)Study completedNCT03565003
What this trial is testing

A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China

Who this might be right for
Non-small Cell Lung CancerHead and Neck CancerEsophageal Cancer+1 more
Jacobio Pharmaceuticals Co., Ltd. 126
Testing effectiveness (Phase 2)Study completedNCT04811027
What this trial is testing

Combination Study With Eftilagimod Alpha (a Soluble LAG-3 Fusion Protein) and Pembrolizumab in Patients With Recurrent or Metastatic HNSCC

Who this might be right for
HNSCC
Immutep S.A.S. 171
Testing effectiveness (Phase 2)Active Not RecruitingNCT06668961
What this trial is testing

SI-B001+SI-B003 Combined With Platinum-based Chemotherapy as First-line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 48
Not applicableEnded earlyNCT01142869
What this trial is testing

An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck

Who this might be right for
Carcinoma, Squamous Cell
Merck KGaA, Darmstadt, Germany 133
Large-scale testing (Phase 3)Temporarily pausedNCT06568172
What this trial is testing

Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer

Who this might be right for
Eyelid Squamous Cell CarcinomaRecurrent Eyelid Squamous Cell CarcinomaRecurrent Skin Acantholytic Squamous Cell Carcinoma+17 more
National Cancer Institute (NCI) 420
Early research (Phase 1)Not Yet RecruitingNCT06383507
What this trial is testing

A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+4 more
Zhejiang University 18
Testing effectiveness (Phase 2)Ended earlyNCT05110781
What this trial is testing

Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site

Who this might be right for
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckResectable Cutaneous Squamous Cell Carcinoma of the Head and NeckStage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
University of California, Davis 1
Large-scale testing (Phase 3)Study completedNCT00003139
What this trial is testing

Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerOral Complications
Radiation Therapy Oncology Group 249
Early research (Phase 1)Ended earlyNCT01987375
What this trial is testing

Cetuximab IRDye800 Study as an Optical Imaging Agent to Detect Cancer During Surgical Procedures

Who this might be right for
Head and Neck Cancer
Eben Rosenthal 1
Testing effectiveness (Phase 2)Study completedNCT03723967
What this trial is testing

FRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Centre Leon Berard 104
Testing effectiveness (Phase 2)Looking for participantsNCT07481058
What this trial is testing

KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Beijing Konruns Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Ended earlyNCT05714553
What this trial is testing

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Who this might be right for
Advanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more
NuCana plc 19
Next Page